  Fact vs. Fiction: The Truth on Biologics and Biosimilars
Written by Gene Quinn President & Founder of IPWatchdog, Inc.
Patent Attorney, Reg. No. 44,294 Zies, Widerman & Malek Blog |
Twitter | Facebook | LinkedIn Posted: December 6, 2009 @ 11:53
am Tell A Friend!   For many months we have been hearing about
the government attempts to “reform” health care in the United
States, and this weekend the United States Senate is actually
working, yes Senators working on a weekend, as the contentious
debate continues. Even a relatively rare Presidential visit to
Capitol Hill is scheduled for later this afternoon, presumably
so President Obama can rally the troops for whatever lies ahead.
While patent policy has not taken center stage in these debates,
it is hard to ignore the under current that rages through the
debates. Health care costs too much, so costs need to be
contained. Of course, market initiatives like a national heath
insurance market, which would lower premiums for everyone
overnight, are not being consi